127 related articles for article (PubMed ID: 38346537)
21. Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).
Biamonti G; Bonomi S; Gallo S; Ghigna C
Cell Mol Life Sci; 2012 Aug; 69(15):2515-26. PubMed ID: 22349259
[TBL] [Abstract][Full Text] [Related]
22. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
24. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
[TBL] [Abstract][Full Text] [Related]
25. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
[TBL] [Abstract][Full Text] [Related]
26. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
Chen S; Chen JZ; Zhang JQ; Chen HX; Yan ML; Huang L; Tian YF; Chen YL; Wang YD
Cancer Lett; 2016 Dec; 383(1):73-84. PubMed ID: 27693633
[TBL] [Abstract][Full Text] [Related]
28. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
29. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
[TBL] [Abstract][Full Text] [Related]
30. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
[TBL] [Abstract][Full Text] [Related]
31. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.
Nishioka R; Itoh S; Gui T; Gai Z; Oikawa K; Kawai M; Tani M; Yamaue H; Muragaki Y
Exp Mol Pathol; 2010 Oct; 89(2):149-57. PubMed ID: 20576520
[TBL] [Abstract][Full Text] [Related]
32. Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancreatic cancer cells.
Katoch A; Suklabaidya S; Chakraborty S; Nayak D; Rasool RU; Sharma D; Mukherjee D; Faheem MM; Kumar A; Sharma PR; Senapati S; Kumar LD; Goswami A
Mol Carcinog; 2018 Sep; 57(9):1102-1115. PubMed ID: 29672923
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
34. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
[TBL] [Abstract][Full Text] [Related]
35. Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity.
Neumann DP; Goodall GJ; Gregory PA
Semin Cell Dev Biol; 2018 Mar; 75():50-60. PubMed ID: 28789987
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
37. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
Elife; 2018 Jul; 7():. PubMed ID: 30059005
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line.
Mi Y; Dong M; Zuo X; Cao Q; Gu X; Mi H; Xiao F
Sci Rep; 2024 May; 14(1):11753. PubMed ID: 38783078
[TBL] [Abstract][Full Text] [Related]
39. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.
Li F; Dai L; Niu J
J Cell Physiol; 2020 Nov; 235(11):7780-7790. PubMed ID: 31774184
[TBL] [Abstract][Full Text] [Related]
40. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
